CCA - Cancer biology and immunology (VUmc)

Research output

Research output per year 1979 2017 2018 2019 2020 2021 2022 2023 2024

• 3527 Article
• 473 Review article
• 195 Meeting Abstract
• 151 Comment/Letter to the editor
• 421 More
  • 116 Chapter
  • 84 Letter
  • 76 Phd-Thesis - Research and graduation internal
  • 59 Editorial
  • 24 Erratum/Corrigendum
  • 17 Conference contribution
  • 10 Short survey
  • 8 Report
  • 6 Abstract
  • 4 Book
  • 4 Paper
  • 4 Phd-Thesis - Research and graduation external
  • 3 Poster
  • 2 Inaugural speech
  • 1 Book editing
  • 1 Digital or Visual Products
  • 1 Software
  • 1 Patent

Research output per year

Research output per year

Search results

• 2024

  Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL

  Campanella, A., Capasso, A., Heltai, S., Taccetti, C., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F., Sant'Antonio, E., & 24 othersColia, M., Combi, C., Levi, S., Kater, A. P., Hazenberg, M., Nijhof, I. S., Hofsink, Q., Demosthenous, C., Kotaskova, J., Zaleska, J., Vrbacky, F., Raya, A. M., Bisogno, D., Tripoli, I. E., Popov, V. M., Roman, V., Stavroyianni, N., Karypidou, M., Scarano, E., Locatelli, M., Frenquelli, M., Scarfò, L., Stamatopoulos, K. & Ghia, P., Apr 2024, In: American journal of hematology. 99, 4, p. 745-750 6 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Mapping the roots of specialist disparities—Authors’ reply

  Mulder, L., Wouters, A., Akwiwu, E. U., Koster, A. S., Peerdeman, S. M., Salih, M. & Kusurkar, R. A., 1 Jan 2024, In: The Lancet Regional Health - Europe. 36, 100815.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Pembrolizumab plus chemotherapy for advanced gastric cancer

  Schutte, T., Derks, S. & van Laarhoven, H. W. M., 1 Feb 2024, In: The Lancet Oncology. 25, 2, p. e51

  Research output: Contribution to journal › Letter › Academic › peer-review

• Seasonal variation of anti-PD-1 outcome in melanoma—Results from a Dutch patient cohort

  Borgers, J. S. W., Burgers, F. H., Schina, A., van Not, O. J., van den Eertwegh, A. J. M., Blank, C. U., Aarts, M. J. B., van den Berkmortel, F. W. P. J., de Groot, J. W. B., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Boer, A. M. S., van der Veldt, A. A. M., Vreugdenhil, G., Boers-Sonderen, M. J., Wouters, M. W. J. M., Suijkerbuijk, K. P. M., van Thienen, J. V., & 1 othersHaanen, J. B. A. G., Jan 2024, In: Pigment Cell and Melanoma Research. 37, 1, p. 15-20 6 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
• 2023

  Age- and gender-matched controls needed for platelet-based biomarker studies

  Sabrkhany, S., Kuijpers, M. J. E., van Kuijk, S. M. J., Griffioen, A. W. & Oude Egbrink, M. G. A., 1 Jun 2023, In: Haematologica. 108, 6, p. 1667-1670 4 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study

  Nahi, H., Usmani, S. Z., Mateos, M-V., van de Donk, N. W. C. J., Oriol, A., Plesner, T., Bandyopadhyay, N., Hellemans, P., Tromp, B., Nnane, I., Zemlickis, D., Chari, A. & Moreau, P., 2023, In: Leukemia and Lymphoma. 64, 2, p. 468-472 5 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001

  Janssen, L. L. G., Westers, T. M., Rovers, J., Valk, P. J. M., Cloos, J., de Gruijl, T. D. & van de Loosdrecht, A. A., 2 Nov 2023, In: HemaSphere. 7, 11, p. E968

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment

  Stevens, W. B. C., Los-de Vries, G. T., Langois-Jacques, C., Clear, A. J., Stathi, P., Sander, B., Rosenwald, A., Calaminici, M., Hoster, E., Hiddemann, W., Gaulard, P., Salles, G., Klapper, W., Xerri, L., Burton, C., Tooze, R. M., Smith, A. G., Buske, C., Scott, D. W., Natkunam, Y., & 11 othersAdvani, R., Sehn, L. H., Raemaekers, J., Gribben, J., Lockmer, S., Kimby, E., Kersten, M. J., Maucort-Boulch, D., Ylstra, B., van Dijk, E. & de Jong, D., 5 Apr 2023, In: HemaSphere. 7, 4, p. E863

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA

  Chamuleau, M. E. D., Veltmaat, N., Zhong, Y., de Jesus, F. M., Tan, G. W., Bult, J. A. A., Terpstra, M. M., Mutsaers, P. G. N. J., Stevens, W. B. C., Mous, R., Vermaat, J. S. P., Noordzij, W., Verschuuren, E. A. M., Kok, K., Kluiver, J. L., Diepstra, A., Plattel, W. J., van den Berg, A. & Nijland, M., 1 Dec 2023, In: Journal of Hematology and Oncology. 16, 1, 104.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

  Groen, K., Schjesvold, F. H., van der Holt, B., Levin, M-D., Seefat, M. R., Hansson, M., Leys, M. B. L., Regelink, J. C., Waage, A., Szatkowski, D., Axelsson, P., Hieu Do, T., Svirskaite, A., van der Spek, E., Haukas, E., Knut-Bojanowska, D., Ypma, P. F., Blimark, C. H., Mellqvist, U-H., van de Donk, N. W. C. J., & 5 othersSonneveld, P., Klostergaard, A., Vangsted, A. J., Abildgaard, N. & Zweegman, S., 30 Sept 2023, In: HemaSphere. 7, 9, p. E940

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• Letter regarding “Acceptability and feasibility of neurocognitive assessments with adults with primary brain cancer and brain metastasis: A systematic review”

  Gorter, M., Röttgering, J. G., Belgers, V., de Witt Hamer, P. C., Douw, L. & Klein, M., 1 Oct 2023, In: Neuro-Oncology Practice. 10, 5, p. 491-492 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

• Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial

  Bos, E. M., Binda, E., Verploegh, I. S. C., Wembacher, E., Hoefnagel, D., Balvers, R. K., Korporaal, A. L., Conidi, A., Warnert, E. A. H., Trivieri, N., Visioli, A., Zaccarini, P., Caiola, L., van Wijck, R., van der Spek, P., Huylebroeck, D., Leenstra, S., Lamfers, M. L. M., Ram, Z., Westphal, M., & 5 othersNoske, D., Legnani, F., DiMeco, F., Vescovi, A. L. & Dirven, C. M. F., Dec 2023, In: Molecular Cancer. 22, 1, p. 129 129.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: A population-based study

  Geerdes, E. E., Durmaz, M. J., Lugtenburg, P. J., Chamuleau, M. E. D., Visser, O., Issa, D. E., Brouwer, R. E., Posthuma, E. F. M., Zijlstra, J. M., Kersten, M. J. & Dinmohamed, A. G., 12 Sept 2023, In: Blood. 7, 17, p. 4869-4873 5 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target

  Hiemcke-Jiwa, L. S., Meister, M. T., Martin, E., Dierselhuis, M. P., Haveman, L. M., Meijers, R. W. J., Tops, B. B. J., Wesseling, P., van Diest, P. J., van Gorp, J. M., Hehir-Kwa, J. Y., van Belzen, I. A. E. M., Bonenkamp, J. J., van Noesel, M. M., Flucke, U. & Kester, L. A., 1 Jan 2023, In: Acta Neuropathologica. 145, 1, p. 149-152 4 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• Prognostic value of positron emission tomography/computed tomography in transplant-eligible newly diagnosed multiple myeloma patients from CASSIOPEIA: the CASSIOPET study

  Kraeber-Bodéré, F., Zweegman, S., Perrot, A., Hulin, C., Caillot, D., Facon, T., Leleu, X., Belhadj, K., Itti, E., Karlin, L., Bailly, C., Levin, M-D., Minnema, M. C., Jamet, B., Bodet-Milin, C., de Keizer, B., Béné, M. C., Avet-Loiseau, H., Sonneveld, P., Pei, L., & 6 othersRigat, F., de Boer, C., Vermeulen, J., Kampfenkel, T., Lambert, J. R. & Moreau, P., 1 Feb 2023, In: Haematologica. 108, 2, p. 621-626 6 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  5 Citations (Scopus)

• Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions

  Burger, E., Baussano, I., Kim, J. J., Laprise, J-F., Berkhof, J., Schiller, J. T., Canfell, K., Prem, K., Brisson, M., Jit, M. & Barnabas, R. V., 17 Apr 2023, In: Vaccine. 41, 16, p. 2648-2649 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  1 Citation (Scopus)

• Reply to P. Castle et al

  Berkhof, J., Dick, S., Kremer, W., Bleeker, M. & Meijer, C., 10 Jan 2023, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41, 2, p. 420-422 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access

• The modes of angiogenesis: an updated perspective

  Dudley, A. C. & Griffioen, A. W., 1 Nov 2023, In: Angiogenesis. 26, 4, p. 477-480 4 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  3 Citations (Scopus)
• 2022

  High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma

  Aydin, M., Tang, M. W., Wondergem, M. J., de Leeuw, D. C., Wegman, J. J., Biemond, B. J., van de Donk, N. W. C. J., Zweegman, S., Meijer, E. & Nur, E., Mar 2022, In: British journal of haematology. 196, 6, p. e67-e70

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Reply to “von Hippel–Lindau disease integrated care pathway: Centralizing, expanding specialists’ theatre, and measuring improvement”

  van Leeuwaarde, R. S., Wolters, W. P. G., Dreijerink, K. M. A. & Giles, R. H., 15 Nov 2022, In: Cancer. 128, 22, p. 4029 1 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

• Silicone Particle Migration: A Misleading Report

  Spoor, J., de Jong, D. & van Leeuwen, F. E., 1 Apr 2022, In: Aesthetic Surgery Journal. 42, 4, p. NP261-NP262

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  1 Citation (Scopus)
• 2021

  DNA vs cDNA FLT3-ITD allelic ratio and length measurements in adult acute myeloid leukemia

  Cucchi, D. G., Vonk, C. M., Rijken, M., Kavelaars, F., Merle, P., Verhoef, E., Venniker-Punt, B., Kwidama, Z. J., Gradowska, P., Löwenberg, B., Janssen, J. J. W. M., Cloos, J. & Valk, P. J. M., 9 Nov 2021, In: Blood advances. 5, 21, p. 4476-4479 4 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  4 Citations (Scopus)

• GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types

  Sievers, P., Stichel, D., Sill, M., Schrimpf, D., Sturm, D., Selt, F., Ecker, J., Kazdal, D., Miele, E., Kranendonk, M. E. G., Tops, B. B. J., Kohlhof-Meinecke, P., Beschorner, R., Kramm, C. M., Hasselblatt, M., Reifenberger, G., Capper, D., Wesseling, P., Stenzinger, A., Milde, T., & 7 othersKorshunov, A., Witt, O., Pfister, S. M., Wick, W., von Deimling, A., Jones, D. T. W. & Sahm, F., Dec 2021, In: Acta Neuropathologica. 142, 6, p. 1065-1069 5 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  14 Citations (Scopus)

• Letter comments on: The effects of antibiotics on the efficacy of immune-checkpoint inhibitors in non-small cell lung cancer patients differ according to PD-L1 expression

  Leonetti, A., Giudice, G. C., Perrone, F., Tiseo, M. & Giovannetti, E., Nov 2021, In: European Journal of Cancer. 157, p. 520-522 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

• Phosphoproteomic characterization of primary AML samples and relevance for response toward FLT3-inhibitors

  Cucchi, D. G. J., van Alphen, C., Zweegman, S., van Kuijk, B., Kwidama, Z. J., Al Hinai, A., Henneman, A. A., Knol, J. C., Piersma, S. R., Pham, T. V., Jimenez, C. R., Cloos, J. & Janssen, J. J. W. M., 2021, (E-pub ahead of print) In: HemaSphere. e606.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  12 Citations (Scopus)

• Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies

  Van Der Horst, H. J., Oostindie, S. C., Cillessen, S. A. G. M., Gelderloos, A. T., Overdijk, M. B., Nijhof, I. S., Zweegman, S., Chamuleau, M. E. D., Breij, E. C. W. & Mutis, T., Jan 2021, In: HemaSphere. 5, 1, p. E504

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Prevalence of medulloblastoma in basal cell nevus syndrome patients with a PTCH1 mutation

  Verkouteren, B. J. A., Cosgun, B., Vermeulen, R. J., Reinders, M. G. H. C., van Geel, M., Gille, J. J. P. & Mosterd, K., 1 Jun 2021, In: Neuro-oncology. 23, 6, p. 1035-1036 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  3 Citations (Scopus)

• Survival in primary myelofibrosis: A population-based analysis in the Netherlands

  Slot, S., Dinmohamed, A. G., Visser, O., Te Boekhorst, P. A. W. & Zweegman, S., 2021, (Accepted/In press) In: HemaSphere. e595.

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  1 Citation (Scopus)
• 2020

  ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases

  van de Stadt, E. A., Yaqub, M., Bahce, I. & Hendrikse, N. H., 1 Feb 2020, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 61, 2, p. 305 1 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

• Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients

  Frerichs, K. A., Bosman, P. W. C., van Velzen, J. F., Fraaij, P. L. A., Koopmans, M. P. G., Rimmelzwaan, G. F., Nijhof, I. S., Bloem, A. C., Mutis, T., Zweegman, S. & van de Donk, N. W. C. J., 1 Jun 2020, In: Haematologica. 105, 6, p. E302-E306 e302-e306.

  Research output: Contribution to journal › Letter › Academic › peer-review
  47 Citations (Scopus)

• Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast

  de Boer, M., Hauptmann, M., Hijmering, N. J., van Noesel, C. J. M., Rakhorst, H. A., Meijers-Heijboer, H. E. J., de Boer, J. P., van der Hulst, R. R. W. J., de Jong, D. & van Leeuwen, F. E., 10 Sept 2020, In: Blood. 136, 11, p. 1368-1372 5 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  22 Citations (Scopus)

• In Ph+BCR-ABL1^P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent

  Baccarani, M., Iacobucci, I., Chiaretti, S., Foà’, R., Balasubramanian, P., Paietta, E., Foroni, L., Jeromin, S., Izzo, B., Spinelli, O., Varma, N., Menif, S., Terragna, C., Seth, T., Bidet, A., Coriu, D., Lunghi, F., Mayer, J., Scappini, B., Langabeer, S., & 24 othersMaier, J., Burt, E., Candoni, A., Albano, F., Luppi, M., Zupan, I., Lion, T., Zadro, R., di Raimondo, F., Poopak, B., Rege-Cambrin, G., Annunziata, M., Ayala, A., Salinas-Viedma, V., Ines Prado, A., Milner, B., Galimberti, S., Janssen, J., Polli, V., Comba, L., Borsellino, B., Annibali, O., Crugnola, M. & Passamonti, F., 1 Mar 2020, In: Leukemia. 34, 3, p. 929-931 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  5 Citations (Scopus)

• Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma

  Holthof, L. C., van der Horst, H. J., van Hal-van Veen, S. E., Ruiter, R. W. J., Li, F., Buijze, M., Andersen, M. N., Yuan, H., de Bruijn, J., van de Donk, N. W. C. J., Lokhorst, H. M., Zweegman, S., Groen, R. W. J. & Mutis, T., 31 Jan 2020, In: Haematologica. 105, 2, p. e80-e83

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  11 Citations (Scopus)

• Re: Myeloblasts in normal bone marrows expressing leukaemia-associated immunophenotypes

  Hanekamp, D., Bachas, C., van de Loosdrecht, A., Ossenkoppele, G. & Cloos, J., Feb 2020, In: Pathology. 52, 2, p. 289-291 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  10 Citations (Scopus)

• WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup?

  Liu, A. P. Y., Priesterbach-Ackley, L. P., Orr, B. A., Li, B. K., Gudenas, B., Reddingius, R. E., Suñol, M., Lavarino, C. E., Olaciregui, N. G., Santa-María López, V., Fisher, M. J., Hazrati, L. N., Bouffet, E., Huang, A., Robinson, G. W., Wesseling, P., Northcott, P. A. & Gajjar, A., 1 Oct 2020, In: Acta Neuropathologica. 140, 4, p. 595-597 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  6 Citations (Scopus)
• 2019

  Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma

  Mendeville, M., Roemer, M. G. M., van den Hout, M. F. C. M., Los-de Vries, G. T., Bladergroen, R., Stathi, P., Hijmering, N. J., Rosenwald, A., Ylstra, B. & de Jong, D., 24 Jan 2019, In: Blood. 133, 4, p. 377-380 4 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  21 Citations (Scopus)

• Can we optimize the selection of patients with lung cancer suitable for EGFR+MET double inhibition?

  Leonetti, A., Tiseo, M., Rolfo, C., Van Der Steen, N., Peters, G. J. & Giovannetti, E., 1 Jan 2019, In: JCO Precision Oncology. 3

  Research output: Contribution to journal › Letter › Academic › peer-review
  1 Citation (Scopus)

• CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

  Naik, J., Themeli, M., de Jong-Korlaar, R., Ruiter, R. W. J., Poddighe, P. J., Yuan, H., de Bruijn, J. D., Ossenkoppele, G. J., Zweegman, S., Smit, L., Mutis, T., Martens, A. C. M., van de Donk, N. W. C. J. & Groen, R. W. J., 28 Feb 2019, In: Haematologica. 104, 3, p. e100-e103

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  83 Citations (Scopus)

• Comment on ‘The detection rate of human papillomavirus in well-differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?’

  Taibjee, S., Carr, R., Craig, P. & Radonic, T., 1 Dec 2019, In: British Journal of Dermatology. 181, 6, p. 1343-1345 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  1 Citation (Scopus)

• Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma

  van de Donk, N. W. C. J., Casneuf, T., Di Cara, A., Parren, P. W., Zweegman, S., van Kessel, B., Lokhorst, H. M., Usmani, S. Z., Lonial, S., Richardson, P. G., Chiu, C., Mutis, T., Nijhof, I. S. & Sasser, A. K., 1 Feb 2019, In: British journal of haematology. 184, 3, p. 475-479 5 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  17 Citations (Scopus)

• Induction response criteria in acute myeloid leukaemia: implications of a flow cytometric measurable residual disease negative test in refractory adults

  on behalf of the UK NCRI AML Trial Group & on behalf of the HOVON AML Trial Group, 1 Jul 2019, In: British journal of haematology. 186, 1, p. 130-133

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  7 Citations (Scopus)

• In Regard to Keall et al

  Dahele, M. & Verbakel, W., 1 Jan 2019, In: International Journal of Radiation Oncology Biology Physics. 103, 1, p. 282-283 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  2 Citations (Scopus)

• Intestinal lymphangiectasia—A novel finding in Van Maldergem syndrome challenging the role of lymphedema for the distinction from Hennekam syndrome

  de Meij, T. G. J., Zwijnenburg, P. J. G., Broers, C. J. M. & Bökenkamp, A., Jul 2019, In: American Journal of Medical Genetics, Part A. 179, 7, p. 1398-1399 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  1 Citation (Scopus)

• Phase I dose-escalation study of brentuximab-vedotin combined with dexamethasone, high-dose cytarabine and cisplatin, as salvage treatment in relapsed/refractory classical hodgkin lymphoma: The HOVON/LLPC transplant brave study

  Hagenbeek, A., Mooij, H., Zijlstra, J., Lugtenburg, P., van Imhoff, G., Nijland, M., Tonino, S., Hutchings, M., Spiering, M., Liu, R., van Tinteren, H. & Kersten, M. J., 31 Mar 2019, In: Haematologica. 104, 4, p. e151-e153

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  23 Citations (Scopus)

• Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma

  Deenen, N. J., Koens, L., Jaspars, E. H., Vermeer, M. H., Willemze, R., de Rie, M. A. & Bekkenk, M. W., 1 Feb 2019, In: British Journal of Dermatology. 180, 2, p. 411-412 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  6 Citations (Scopus)
• 2018

  Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

  Franssen, L. E., Nijhof, I. S., Couto, S., Levin, M. D., Bos, G. M. J., Broijl, A., Klein, S. K., Ren, Y., Wang, M., Koene, H. R., Bloem, A. C., Beeker, A., Faber, L. M., van der Spek, E., Raymakers, R., Leguit, R. J., Sonneveld, P., Zweegman, S., Lokhorst, H., Mutis, T., & 3 othersThakurta, A., Qian, X. & van de Donk, N. W. C. J., 31 Jul 2018, In: Haematologica. 103, 8, p. e368-e371

  Research output: Contribution to journal › Letter › Academic › peer-review

  Open Access
  43 Citations (Scopus)

• Plasma FGF23 is not elevated in prostate cancer

  Vlot, M. C., Bijnsdorp, I., den Heijer, M., de Jonge, R., van Moorselaar, R. J. A. & Heijboer, A. C., 1 Mar 2018, In: Clinica Chimica Acta. 478, p. 129-131 3 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
  3 Citations (Scopus)

• Re: Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution

  Dreijerink, K. M. A., 1 Jun 2018, In: Surgery (United States). 163, 6, p. 1325-1329 5 p.

  Research output: Contribution to journal › Letter › Academic › peer-review

• Ultra-early aneurysm treatment

  Post, R., Hoogmoed, J., Verbaan, D. & Vandertop, W. P., 1 Nov 2018, In: Journal of neurosurgery. 129, 5, p. 1374-1375 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review
• 2017

  Author response: Acute intermittent porphyria-related leukoencephalopathy

  Van Der Knaap, M. S. & Kevelam, S. H., 14 Feb 2017, In: Neurology. 88, 7, p. 718-719 2 p.

  Research output: Contribution to journal › Letter › Academic › peer-review